Tumor resistance

OncoImmunology

Volumn 1, Issue 8, 2012, Pages 1355-1359

  Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dormancy; Fibroblasts; Microenvironment; Neighbor suppression; Tumor resistance

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLNITROSOUREA; MYC PROTEIN; NOTCH RECEPTOR; UVOMORULIN;

BREAST CANCER; CANCER GROWTH; CANCER RESISTANCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CONTACT; CELL INTERACTION; CELL REGENERATION; EMBRYO DEVELOPMENT; FIBROBLAST; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFLAMMATION; MALIGNANT TERATOMA; MALIGNANT TRANSFORMATION; MICROMETASTASIS; NONHUMAN; ONCOGENE MYC; ONCOGENE SRC; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SKIN CANCER; TISSUE STRUCTURE; TUMOR MICROENVIRONMENT;

EID: 84886945117     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.22194     Document Type: Review

References (26)

1. Ehrlich P. Über den jetzigen Stand der Karzinomforschung. Ned Tijdschr Geneeskd 1909; 5:273-90.
2. Seluanov A, Hine C, Bozzella M, Hall A, Sasahara TH, Ribeiro AA, et al. Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell 2008; 7:813-23; PMID:18778411; http://dx.doi.org/10.1111/j.1474-9726.2008.00431.x.
3. Seluanov A, Hine C, Azpurua J, Feigenson M, Bozzella M, Mao Z, et al. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci USA 2009; 106:19352-7; PMID:19858485; http://dx.doi.org/10.1073/pnas.0905252106.
4. Beerenblum I. General Pathology. 2nd ed. Florey H, editor. Philadelphia, PA: Saunders; 1962.
5. Pantel K, Riethmüller G. Micrometastasis detection and treatment with monoclonal antibodies. Curr Top Microbiol Immunol 1996; 213:1-18; PMID:8814999; http://dx.doi.org/10.1007/978-3-642-80071-9_1.
6. Woodruff M. The Walter Hubert Lecture, 1982. Interaction of cancer and host. Br J Cancer 1982; 46:313-22; PMID:6982056; http://dx.doi.org/10.1038/bjc.1982.206.
7. Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 1975; 72:3585-9; PMID:1059147; http://dx.doi.org/10.1073/pnas.72.9.3585.
8. Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011; 17:320-9; PMID:21383745; http://dx.doi.org/10.1038/nm.2328.
9. Partanen JI, Nieminen AI, Mäkelä TP, Klefstrom J. Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci USA 2007; 104:14694-9; PMID:17766436; http://dx.doi.org/10.1073/pnas.0704677104.
10. Stoker MG, Shearer M, O'Neill C. Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1966; 1:297-310; PMID:4291022.
11. Alexander DB, Ichikawa H, Bechberger JF, Valiunas V, Ohki M, Naus CC, et al. Normal cells control the growth of neighboring transformed cells independent of gap junctional communication and SRC activity. Cancer Res 2004; 64:1347-58; PMID:14973064; http://dx.doi.org/10.1158/0008-5472.CAN-03-2558.
12. Alt-Holland A, Zhang W, Margulis A, Garlick JA. Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Semin Cancer Biol 2005; 15:84-96; PMID:15652453; http://dx.doi.org/10.1016/j.semcancer.2004.08.007.
13. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, et al. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 2002; 94:1494-503; PMID:12359858; http://dx.doi.org/10.1093/jnci/94.19.1494.
14. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997; 137:231-45; PMID:9105051; http://dx.doi.org/10.1083/jcb.137.1.231.
15. Glick AB, Yuspa SH. Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers. Semin Cancer Biol 2005; 15:75-83; PMID:15652452; http://dx.doi.org/10.1016/j.semcancer.2004.08.008.
16. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002; 62:2162-8; PMID:11929839.
17. Dolberg DS, Hollingsworth R, Hertle M, Bissell MJ. Wounding and its role in RSV-mediated tumor formation. Science 1985; 230:676-8; PMID:2996144; http://dx.doi.org/10.1126/science.2996144.
18. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004; 117:1495-502; PMID:14996910; http://dx.doi.org/10.1242/jcs.01000.
19. Zhang W, Remenyik E, Zelterman D, Brash DE, Wikonkal NM. Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci USA 2001; 98:13948-53; PMID:11707578; http://dx.doi.org/10.1073/pnas.241353198.
20. Hennings H, Lowry DT, Robinson VA, Morgan DL, Fujiki H, Yuspa SH. Activity of diverse tumor promoters in a keratinocyte co-culture model of initiated epidermis. Carcinogenesis 1992; 13:2145-51; PMID:1423887; http://dx.doi.org/10.1093/carcin/13.11.2145.
21. O'Connor PMLT, Lapointe TK, Beck PL, Buret AG. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflamm Bowel Dis 2010; 16:1411-20; PMID:20155848.
22. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell 2010; 17:135-47; PMID:20138012; http://dx.doi.org/10.1016/j.ccr.2009.12.041.
23. Flaberg E, Guven H, Savchenko A, Pavlova T, Kashuba V, Szekely L, et al. The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth. Int J Cancer 2012; 131:2274-83; PMID:22396138; http://dx.doi.org/10.1002/ijc.27521.
24. Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer 2011; 128:2793-802; PMID:20715102; http://dx.doi.org/10.1002/ijc.25612.
25. Harding C, Pompei F, Lee EE, Wilson R. Cancer suppression at old age. Cancer Res 2008; 68:4465-78; PMID:18519710; http://dx.doi.org/10.1158/0008-5472.CAN-07-1670.
26. Caulin AF, Maley CC. Peto's Paradox: evolution's prescription for cancer prevention. Trends Ecol Evol 2011; 26:175-82; PMID:21296451; http://dx.doi.org/10.1016/j.tree.2011.01.002.